Cargando…

Urinary Exosomal Thyroglobulin in Thyroid Cancer Patients With Post-ablative Therapy: A New Biomarker in Thyroid Cancer

Background: Most patients with thyroid cancer typically receive thyroidectomy with ablative radioactive iodine therapy. Such patients were followed with thyroid ultrasonography and serial serum thyroglobulin evaluation. Exosomes are nanovesicles secreted into extracellular environments, including pl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Tse-Ying, Wang, Chih-Yuan, Chen, Kuen-Yuan, Huang, Li-Ting
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7308545/ https://www.ncbi.nlm.nih.gov/pubmed/32612576 http://dx.doi.org/10.3389/fendo.2020.00382

Ejemplares similares

The Role of Thyroglobulin in Preoperative and Postoperative Evaluation of Patients With Differentiated Thyroid Cancer
por: Li, Sha, et al.
Publicado: (2022)

Urinary Exosomal Tissue TIMP and Angiopoietin-1 Are Preoperative Novel Biomarkers of Well-Differentiated Thyroid Cancer
por: Wang, Chih-Yuan, et al.
Publicado: (2022)

The Role of Pre-ablative Stimulated Thyroglobulin and Thyroglobulin/ Thyroid-Stimulating Hormone Ratio for Predicting Metastasis in Thyroid Cancer
por: Demir, Fadime, et al.
Publicado: (2019)

Nitric oxide, thyroglobulin, and calcitonin: unraveling the nature of thyroid nodules
por: Samardzic, Vladimir S., et al.
Publicado: (2023)

Utility of Stimulated Thyroglobulin in Reclassifying Low Risk Thyroid Cancer Patients’ Following Thyroidectomy and Radioactive Iodine Ablation: A 7-Year Prospective Trial
por: Jammah, Anwar A., et al.
Publicado: (2021)

Stimulated thyroglobulin and pre-ablation antithyroglobulin antibody products can predict the response to radioiodine therapy of TgAb-positive differentiated thyroid cancer patients: a retrospective study
por: Han, Na, et al.
Publicado: (2023)

FRTL-5 Rat Thyroid Cells Release Thyroglobulin Sequestered in Exosomes: A Possible Novel Mechanism for Thyroglobulin Processing in the Thyroid
por: Vlasov, Pavel, et al.
Publicado: (2016)

The clinical meaning of pre- and post-ablation thyroglobulin levels at first radioiodine therapy in patients with papillary thyroid cancer
por: Kim, Hee Kyung, et al.
Publicado: (2020)

High Thyroglobulin Antibody Following Intravenous Immunoglobulin Therapy in Athyreotic Differentiated Thyroid Cancer Patients
por: Lau, Kheng Joe, et al.
Publicado: (2022)

Predictive Value of Thyroglobulin Changes for the Curative Effect of Radioiodine Therapy in Patients With Metastatic Differentiated Thyroid Carcinoma
por: Wang, Congcong, et al.
Publicado: (2021)

Lung Metastases From Papillary Thyroid Cancer With Persistently Negative Thyroglobulin and Elevated Thyroglobulin Antibody Levels During Radioactive Iodine Treatment and Follow-Up: Long-Term Outcomes and Prognostic Indicators
por: Qiu, Zhong-Ling, et al.
Publicado: (2020)

Utility of Stimulated Thyroglobulin in the Differentiate Thyroid Cancer
por: Romero, Fabiola, et al.
Publicado: (2021)

Ultrasonography, Cytology, and Thyroglobulin Measurement Results of Cervical Nodal Metastasis in Patients With Unclear Papillary Thyroid Carcinoma
por: Lim, Jong Heon, et al.
Publicado: (2019)

Outcome of Patients With Differentiated Thyroid Cancer Treated With 131-Iodine on the Basis of a Detectable Serum Thyroglobulin Level After Initial Treatment
por: Klain, Michele, et al.
Publicado: (2019)

Clinical Analysis of Preoperative Anti-thyroglobulin Antibody in Papillary Thyroid Cancer Between 2011 and 2015 in Beijing, China: A Retrospective Study
por: Jia, Xiaomeng, et al.
Publicado: (2020)

Two Cases of Armour Thyroid Interference in Thyroglobulin Monitoring for Thyroid Cancer
por: Ponder, Michelle, et al.
Publicado: (2021)

Thyroglobulin levels in COVID-19-positive patients: Correlations with thyroid function tests, inflammatory markers, and glucocorticoid use
por: Świątkowska-Stodulska, Renata, et al.
Publicado: (2023)

Prognostic Significance of Thyroglobulin Antibodies in Differentiated Thyroid Cancer
por: Reverter, Jordi L., et al.
Publicado: (2020)

Combination of Stimulated Thyroglobulin and Antithyroglobulin Antibody Predicts the Efficacy and Prognosis of (131)I Therapy in Patients With Differentiated Thyroid Cancer Following Total Thyroidectomy: A Retrospective Study
por: Pan, Mengjiao, et al.
Publicado: (2022)

Nomogram model based on preoperative serum thyroglobulin and clinical characteristics of papillary thyroid carcinoma to predict cervical lymph node metastasis
por: Chang, Qungang, et al.
Publicado: (2022)

Actions of Thyroid Hormones on Thyroid Cancers
por: Mousa, Shaker A., et al.
Publicado: (2021)

Is There a Role for Unstimulated Thyroglobulin Velocity in Predicting Recurrence in Papillary Thyroid Carcinoma Patients with Detectable Thyroglobulin after Radioiodine Ablation?
por: Wong, Hilda, et al.
Publicado: (2012)

The Efficacy and Safety of Radiofrequency Ablation for Bilateral Papillary Thyroid Microcarcinoma
por: Yan, Lin, et al.
Publicado: (2021)

Correlation analysis of serum thyroglobulin, thyroid-stimulating hormone levels, and thyroid-cancer risk in thyroid nodule surgery
por: Shuai, Jin-Hao, et al.
Publicado: (2023)

Is Stimulated Thyroglobulin Necessary after Ablation in All Patients with Papillary Thyroid Carcinoma and Basal Thyroglobulin Detectable by a Second-Generation Assay?
por: Rosario, Pedro Weslley, et al.
Publicado: (2015)

The Ablation of Thyroid Nodule’s Afferent Arteries Before Radiofrequency Ablation: Preliminary Data
por: Offi, Chiara, et al.
Publicado: (2021)

Construction of a Signature Model to Predict the Radioactive Iodine Response of Papillary Thyroid Cancer
por: Liu, Lina, et al.
Publicado: (2022)

Changes in Anti-Thyroglobulin IgG Glycosylation Patterns in Hashimoto's Thyroiditis Patients
por: Yuan, Shanshan, et al.
Publicado: (2015)

New Therapies for Advanced Thyroid Cancer
por: Laha, Diprajan, et al.
Publicado: (2020)

Use and Isolation of Urinary Exosomes as Biomarkers for Diabetic Nephropathy
por: Musante, Luca, et al.
Publicado: (2014)

Efficacy of radiofrequency ablation for metastatic papillary thyroid cancer with and without initial biochemical complete status
por: Chen, Wen-Chieh, et al.
Publicado: (2022)

Bioactivity of Thyroid Hormone Analogs at Cancer Cells
por: Davis, Paul J., et al.
Publicado: (2018)

Serum thyroglobulin as a preclinical tumour marker in subgroups of thyroid cancer.
por: Thoresen, S. O., et al.
Publicado: (1988)

THYROGLOBULIN AS A TUMOR MARKER IN DIFFERENTIATED THYROID CANCER – CLINICAL CONSIDERATIONS
por: Prpić, Marin, et al.
Publicado: (2018)

The Prognostic Role of Postablative Non-Stimulated Thyroglobulin in Differentiated Thyroid Cancer
por: Szujo, Szabina, et al.
Publicado: (2021)

Pathology confirmation of the efficacy and safety of microwave ablation in papillary thyroid carcinoma
por: Ding, Min, et al.
Publicado: (2022)

Preoperatively Predicting the Central Lymph Node Metastasis for Papillary Thyroid Cancer Patients With Hashimoto’s Thyroiditis
por: Min, Yu, et al.
Publicado: (2021)

Significance of radiofrequency ablation in large solid benign thyroid nodules
por: Lin, Yan, et al.
Publicado: (2022)

Thyroid Cancer Persistence in Patients with Unreliable Thyroglobulin Measurement: Circulating microRNA as Candidate Alternative Biomarkers
por: Campennì, Alfredo, et al.
Publicado: (2022)

Analysis of risk factors for intra-cystic hemorrhage in microwave ablation of partially cystic thyroid nodules
por: Fu, Yao, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_7qh7ftslj16j6uktgjburkf8ng